Sodium-Glucose Cotransporter 2 Inhibitor-Associated “Ketoacidosis” Versus “Diabetic Ketoacidosis”: The Importance of Accurate Terminology

被引：0
|
作者：
Tamara Y. Milder
David A. Milder
Jerry R. Greenfield
Richard O. Day
机构：
[1] St. Vincent’s Hospital,Department of Diabetes and Endocrinology
[2] St. Vincent’s Hospital,Department of Clinical Pharmacology and Toxicology
[3] Garvan Institute of Medical Research,Clinical Science Pillar
[4] UNSW Sydney,School of Clinical Medicine, UNSW Medicine & Health, St. Vincent’s Healthcare Clinical Campus
[5] Westmead Hospital,Department of Anaesthesia
[6] St. Vincent’s Hospital,Department of Anaesthesia
[7] University of Sydney,Westmead Clinical School
来源：
Drug Safety | 2023年 / 46卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1303 / 1305
页数：2
相关论文
共 50 条
  • [41] Insulin and glucose infusion could prevent euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter 2 inhibitors
    Ito, Takuya
    Sugasawa, Gen
    Suzuki, Fumitaka
    Sunada, Masatoshi
    Iwamuro, Kenji
    Nakano, Takaaki
    Saito, Masahiro
    Maeba, Satoru
    INDIAN JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 38 (01) : 87 - 91
  • [42] Insulin and glucose infusion could prevent euglycemic diabetic ketoacidosis associated with sodium-glucose cotransporter 2 inhibitors
    Takuya Ito
    Gen Sugasawa
    Fumitaka Suzuki
    Masatoshi Sunada
    Kenji Iwamuro
    Takaaki Nakano
    Masahiro Saito
    Satoru Maeba
    Indian Journal of Thoracic and Cardiovascular Surgery, 2022, 38 : 87 - 91
  • [43] Diabetic Ketoacidosis Associated with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical and Biochemical Characteristics of 29 Cases
    Stamatiades, G. A.
    D'Silva, P.
    Elahee, M.
    Viana, G. M.
    Sideri-Gugger, A.
    Majumdar, S. K.
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2023, 2023
  • [44] Prolonged Diabetic Ketoacidosis Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Postmarketing Cases
    Woronow, Daniel
    Chamberlain, Christine
    Houstoun, Monika
    Munoz, Monica
    ENDOCRINE PRACTICE, 2024, 30 (07) : 603 - 609
  • [45] Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use
    Amianda, Erica A.
    Gavigan, Thomas S.
    Talishinskiy, Toghrul
    Ewing, Douglas R.
    Schmidt, Hans J.
    OBESITY SURGERY, 2021, 31 (08) : 3848 - 3850
  • [46] Two cases of euglycemic diabetic ketoacidosis after bariatric surgery associated with sodium-glucose cotransporter-2 inhibitor use
    Erica A. Amianda
    Thomas S. Gavigan
    Toghrul Talishinskiy
    Douglas R. Ewing
    Hans J. Schmidt
    Obesity Surgery, 2021, 31 : 3848 - 3850
  • [47] Balancing Risks and Benefits: Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis
    Kleinjan, Jan P.
    Blom, Justin
    van Beek, Andre P.
    Bouma, Hjalmar R.
    van Dijk, Peter R.
    METABOLITES, 2024, 14 (03)
  • [48] Postcardiac Surgery Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Cotransporter 2 Inhibitors
    Auerbach, Jonathan S.
    Gershengorn, Hayley B.
    Aljure, Oscar D.
    Lamelas, Joseph
    Patel, Samira S.
    Ferreira, Tanira D.
    Gonzalez, Lazaro A.
    Cabrera, Jorge L.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2023, 37 (06) : 956 - 963
  • [49] Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition
    Peters, Anne L.
    Buschur, Elizabeth O.
    Buse, John B.
    Cohan, Pejman
    Diner, Jamie C.
    Hirsch, Irl B.
    DIABETES CARE, 2015, 38 (09) : 1687 - 1693
  • [50] Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors
    Fleming, Nicola
    Hamblin, Peter Shane
    Story, David
    Ekinci, Elif, I
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (08): : 2475 - 2486
12345